The co-founder of biotech giant Amgen, Rathmann was the Thousand Oaks firm's first chief executive, overseeing the development of blockbuster drugs to boost growth of red and white blood cells. The firm now has a market value of $54 billion. He was 84. Full obituary
COMMENTING POLICY:Readers are encouraged to post comments that are germane to the article. We reserve the right to remove any user, and to delete comments that contain abusive language or personal threats, as well as those that are racist or demeaning. Readers may report comments by clicking "Report Abuse." Once a comment has been flagged, a Baltimore Sun staffer will investigate. Click here for more information on commenting.